Short answer · Medically reviewed summary · Last updated: 2026-05-08
Chordoma is diagnosed through a combination of advanced diagnostic imaging, typically an MRI, and a tissue biopsy that confirms the presence of characteristic brachyury-expressing cells. Because Chordoma is a rare, slow-growing cancer arising from notochord remnants, the diagnostic process often requires specialized pathology review to distinguish it from other bone or soft tissue tumors. How is Chordoma diagnosed? The diagnostic journey for Chordoma usually begins when a patient presents with persistent pain or neurological symptoms related to the tumor's location, most commonly in the sacrum or the base of the skull.
How is Chordoma diagnosed?
How Chordoma is diagnosed: tests, specialists and the diagnostic journey, told by patients and reviewed against medical sources.
Chordoma is diagnosed through a combination of advanced diagnostic imaging, typically an MRI, and a tissue biopsy that confirms the presence of characteristic brachyury-expressing cells. Because Chordoma is a rare, slow-growing cancer arising from notochord remnants, the diagnostic process often requires specialized pathology review to distinguish it from other bone or soft tissue tumors.
How is Chordoma diagnosed?
The diagnostic journey for Chordoma usually begins when a patient presents with persistent pain or neurological symptoms related to the tumor's location, most commonly in the sacrum or the base of the skull. Because these symptoms are non-specific, patients often experience a "diagnostic odyssey," sometimes waiting months or years before a definitive diagnosis is reached. If you have faced delays in your journey, please know that your frustration is heard; 34 members of our Chordoma community at DiseaseMaps.org have navigated these same challenges.
What tests are used to confirm Chordoma?
Physicians utilize several specific tools to confirm the diagnosis:
- Imaging: MRI is the gold standard for visualizing Chordoma, often supplemented by CT scans to evaluate bone destruction.
- Biopsy: A core needle biopsy is essential to obtain tissue for histological examination.
- Immunohistochemistry: Pathologists look for the expression of the protein brachyury, a highly specific marker for Chordoma.
- Differential Diagnosis: Specialists must distinguish Chordoma from chondrosarcoma, metastatic carcinoma, and giant cell tumors, which can look similar on initial scans.
Why is seeing a specialist essential?
Due to the rarity of Chordoma, general practitioners may not encounter it in their entire career. It is critical to be referred to a center of excellence, typically involving a multidisciplinary team including neurosurgeons, orthopedic oncologists, and specialized pathologists. An initial biopsy performed by a non-specialist can sometimes complicate future surgical approaches, so seeking expert consultation early is vital for optimal outcomes.
Next steps
- Request a referral to a sarcoma or skull-base tumor center of excellence.
- Ensure your biopsy tissue is reviewed by a pathologist who specializes in bone and soft tissue tumors.
- Connect with the 34 members of the Chordoma community at DiseaseMaps.org to share experiences and find peer support.
- Keep a detailed symptom diary to help your clinical team track the progression of your condition.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: Portal for rare diseases and orphan drugs
- Chordoma Foundation: Clinical diagnostic guidelines
- OMIM (Online Mendelian Inheritance in Man)
